Fortis Healthcare has announced that its board of directors has approved the extension of Managing Director and Chief Executive Officer Dr Ashutosh Raghuvanshi’s tenure by a further two years. The new term will commence on March 19, 2027, following the completion of his current tenure, which is scheduled to end on March 18, 2027, and is subject to shareholder approval in due course.
The board cited Dr Raghuvanshi’s role in steering the company’s growth and strengthening its position as a leading healthcare provider as a key factor behind the decision. A cardiac surgeon turned healthcare leader with more than three decades of experience, he has led Fortis through a period of operational consolidation and strategic focus, building on his earlier leadership roles at other major hospital chains.
Under his stewardship, Fortis Healthcare has continued to expand its network of hospitals and diagnostics centres while emphasising clinical excellence, patient safety and efficiency. The extension of his tenure is expected to provide continuity in leadership as the company navigates an evolving healthcare landscape, regulatory environment and growth opportunities in India’s hospital sector.
